Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

The coming site-of-care shock for infusions

  • Biopharma , 
  • Payers , 
  • Providers
There’s a major disruption looming in how the site-of-care for infusio…

Read more

Stat

Recon partners explore the enormous potential of repurposing of generics for novel uses in this STAT article

  • In the News

Read more

The growth of small molecule drug classes over time

  • Biopharma
Modern drug discovery is largely based on the identification and valid…

Read more